Efficacy and safety of Chinese patent medicine for urinary tract infections: a systematic review and network meta-analysis
IntroductionChinese patent medicines (CPMs) have garnered increasing attention as therapeutic options for urinary tract infections (UTIs); however, robust evidence supporting their efficacy remains limited. To address this gap, we performed a network meta-analysis (NMA) incorporating both direct and...
Saved in:
| Main Authors: | Jialei Zhao, Haibin Tang, Rutong Xu, Gang Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1622999/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of the effectiveness of single-dose levofloxacin with single-dose fosfomycin pre-urodynamic study related to the incidence of urinary tract infection: a randomized controlled trial
by: Harrina Erlianti Rahardjo, et al.
Published: (2025-07-01) -
Ureteral Stent Induced Urinary Tract Infection and Microbial Inconsistency Between Bladder and Renal Pelvis
by: Useok Choi, et al.
Published: (2021-12-01) -
Efficacy and safety of combined traditional Chinese medicine retention enema for chronic kidney disease stage 2-4: a Meta-analysis
by: Dong Kai-xuan, et al.
Published: (2022-10-01) -
Overview of systematic reviews on Chinese patented oral medicines for promoting blood circulation and removing blood stasis combined with western medicine in the treatment of coronary heart disease angina pectoris
by: Xinyi Chen, et al.
Published: (2025-06-01) -
Lower urinary tract symptoms (LUTS) in males: A review of pathophysiology
by: Suhani Maharajh, et al.
Published: (2015-04-01)